Work

Early PSA decline as a predictor of progression in patients with metastatic castration-naïve prostate cancer (mCNPC) treated with abiraterone acetate and prednisone (AA/P).

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.15_suppl.e17542

Authors: Pedro C. Barata, Iris Yeong- Fung Sheng, Jaleh Fallah, Ruby Gupta, Hong Li, Kimberly D. Allman, Allison Martin, Moshe Chaim Ornstein, Timothy D. Gilligan, Brian I. Rini, Jorge A. Garcia

Institutions: Cleveland Clinic, Beaumont Hospital, Royal Oak

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3030116451

Cites:

Cited by:

Related to: 10